vs
Newsmax Inc.（NMAX）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Newsmax Inc.的1.4倍（$75.5M vs $52.2M），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.8M）
纽斯马克斯公司是一家总部位于美国的媒体广播企业，提供新闻报道、政治评论、观点内容及生活类节目，通过有线电视、官网、移动应用和流媒体平台分发内容，主要面向美国本土受众，核心内容板块侧重保守立场的时事资讯。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NMAX vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$52.2M
自由现金流更多
PBYI
多$12.6M
$1.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.2M | $75.5M |
| 净利润 | $-3.0M | — |
| 毛利率 | 36.7% | 69.3% |
| 营业利润率 | -9.0% | 22.7% |
| 净利率 | -5.7% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.15 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NMAXPBYI
| Q4 25 | $52.2M | $75.5M | ||
| Q3 25 | $45.3M | $54.5M | ||
| Q2 25 | $46.4M | $52.4M | ||
| Q1 25 | $45.3M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | — | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润NMAXPBYI
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $-4.1M | $8.8M | ||
| Q2 25 | $-75.2M | $5.9M | ||
| Q1 25 | $-17.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率NMAXPBYI
| Q4 25 | 36.7% | 69.3% | ||
| Q3 25 | 35.3% | 77.7% | ||
| Q2 25 | 38.0% | 76.5% | ||
| Q1 25 | 47.8% | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率NMAXPBYI
| Q4 25 | -9.0% | 22.7% | ||
| Q3 25 | -15.9% | 17.6% | ||
| Q2 25 | -164.5% | 12.7% | ||
| Q1 25 | -25.5% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率NMAXPBYI
| Q4 25 | -5.7% | — | ||
| Q3 25 | -9.1% | 16.2% | ||
| Q2 25 | -161.9% | 11.2% | ||
| Q1 25 | -38.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）NMAXPBYI
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $-0.03 | $0.17 | ||
| Q2 25 | $-0.59 | $0.12 | ||
| Q1 25 | $-0.49 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $106.0M | $130.3M |
| 总资产 | $239.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NMAXPBYI
| Q4 25 | $20.4M | $97.5M | ||
| Q3 25 | $14.2M | $94.4M | ||
| Q2 25 | $33.8M | $96.0M | ||
| Q1 25 | $126.7M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务NMAXPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NMAXPBYI
| Q4 25 | $106.0M | $130.3M | ||
| Q3 25 | $106.0M | $115.3M | ||
| Q2 25 | $106.9M | $104.7M | ||
| Q1 25 | $177.4M | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产NMAXPBYI
| Q4 25 | $239.8M | $216.3M | ||
| Q3 25 | $233.3M | $202.9M | ||
| Q2 25 | $259.8M | $194.9M | ||
| Q1 25 | $278.2M | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | — | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比NMAXPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 3.4% | 19.1% |
| 资本支出强度资本支出/营收 | 1.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-107.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NMAXPBYI
| Q4 25 | $2.6M | $14.4M | ||
| Q3 25 | $-68.1M | $9.7M | ||
| Q2 25 | $-23.2M | $14.1M | ||
| Q1 25 | $-15.7M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流NMAXPBYI
| Q4 25 | $1.8M | $14.4M | ||
| Q3 25 | $-69.2M | $9.7M | ||
| Q2 25 | $-23.8M | $14.1M | ||
| Q1 25 | $-15.8M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率NMAXPBYI
| Q4 25 | 3.4% | 19.1% | ||
| Q3 25 | -152.9% | 17.7% | ||
| Q2 25 | -51.3% | 26.8% | ||
| Q1 25 | -34.9% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度NMAXPBYI
| Q4 25 | 1.7% | 0.0% | ||
| Q3 25 | 2.4% | 0.0% | ||
| Q2 25 | 1.3% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率NMAXPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NMAX
| Advertising | $33.9M | 65% |
| Affiliate Fee | $8.3M | 16% |
| Subscription And Circulation | $6.2M | 12% |
| Products | $2.6M | 5% |
| Supplement Sales | $1.1M | 2% |
PBYI
暂无分部数据
